Most surgical patients fail to complete prescribed physical therapy exercises, hindering recovery and jeopardizing surgical ...

AMT-130 Huntington’s gene therapy data, FDA Phase III sham-trial push, cash runway, and 2026 catalysts—read now.

A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the ...

Rev. Jesse Jackson died Tuesday morning at age 84.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were ...

Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) to be completed by our partner Jazz in first-line HER2-positive ...

BackFit Health + Spine recognizes the ongoing contributions of Dr. Derek Pruni, principal at its Mesa location, who has ...

Full year 2025 ORLADEYO® net revenue of $601.8 million (+38% y-o-y; +43% y-o-y excluding European ORLADEYO revenue following the sale of the ...

In this episode of Disruption Interruption, Julian Circo, Co-Founder of Hyfe, joins host Karla Jo Helms to discuss revolutionizing respiratory diagnostics. Circo explains how Hyfe uses AI to turn ...